An international collaboration involving PSI and funded by @dfg.de uncovered how certain macrocyclic inhibitors act as so-called ‘molecular glues’ and disrupt cellular signalling. These compounds show therapeutic potential for specific types of cancer. www.pnas.org/doi/10.1073/...